Theodore James Jr. Washburn, the Principal Accounting Officer at Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), recently sold 2,272 shares of common stock. The shares were sold at a price of $34.39 each, ...

We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...

Zentalis Pharmaceuticals Inc (ZNTL) stock saw a decline, ending the day at $1.63 which represents a decrease of $-0.05 or -2.98% from the prior close of $1.68. The stock opened at $1.66 and touched a ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Rising awareness of health issues, an ageing population, and higher disposable incomes are driving India's healthcare boom. Two major players are racing to capitalise on this demand—who has the edge?

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, February 05 based on AAII’s Stock Grades.

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

BioMarin (BMRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Takeda Pharmaceutical Co Ltd (TAK) stock saw a modest uptick, ending the day at $13.32 which represents a slight increase of $0.07 or 0.53% from the prior close of $13.25. The stock opened at $13.23 ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...